Skip to main content
. 2013 Feb 11;110(9):3573–3578. doi: 10.1073/pnas.1219731110

Fig. 2.

Fig. 2.

(A) Time spent immobile in the tail suspension test after physostigmine-induced immobility and its reversal by fluoxetine; n = 9–12 per group. (B) AChE activity in microdissected brain regions following chronic treatment with fluoxetine; n = 5 per group. (C) Time spent immobile in the tail suspension test following an acute bilateral infusion of physostigmine into the hippocampus; n = 7–12 per group. #P = 0.07; *P < 0.05; ***P < 0.001. All data are expressed as mean ± SEM.